OS Therapies Incorporated (OSTX)
OS Therapies will go public soon. The estimated IPO date is July 10, 2024.
IPO Price
$4.00
Shares Offered
2,000,000
Deal Size
$8.00M
OS Therapies Statistics
Total Valuation
OS Therapies has a market cap or net worth of $82.39 million. The enterprise value is $93.79 million.
Market Cap | 82.39M |
Enterprise Value | 93.79M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
OS Therapies has 20.60 million shares outstanding.
Shares Outstanding | 20.60M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | 0.03 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.53 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -1,228.56% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.13M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -4.45M |
Pretax Income | -6.38M |
Net Income | -6.38M |
EBITDA | -3.42M |
EBIT | -4.57M |
Earnings Per Share (EPS) | -$0.31 |
Balance Sheet
The company has $171,480 in cash and $11.57 million in debt, giving a net cash position of -$11.40 million or -$0.55 per share.
Cash & Cash Equivalents | 171,480 |
Total Debt | 11.57M |
Net Cash | -11.40M |
Net Cash Per Share | -$0.55 |
Equity (Book Value) | -17.56M |
Book Value Per Share | -0.85 |
Working Capital | -5.65M |
Cash Flow
Operating Cash Flow | -3.79M |
Capital Expenditures | n/a |
Free Cash Flow | -3.79M |
FCF Per Share | -$0.18 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
OS Therapies does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -7.74% |
FCF Yield | -4.60% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |